CLINICAL_TRIALS
trial_result
· 2012-01-13
Clinical Trial Update: Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluating the effect of Fragmin in the treatment of neuroischemic diabetic foot ulcers has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetic Foot Ulcer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-01-13